Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 78.33
+2.50 (3.30%)
At close: Sep 25, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 1.03 billion as of September 25, 2026. Its market cap has increased by 56.36% in one year.
Market Cap
1.03B
Enterprise Value
1.17B
Revenue
860.69M
Ranking
n/a
PE Ratio
45.55
Stock Price
78.33
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.03B, an increase of 612.69%. That is a compound annual growth rate of 18.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.03B | -5.03% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lactose (India) | 1.42B |
| Parnax Lab | 1.34B |
| Godavari Drugs | 1.27B |
| Aayush Wellness | 1.18B |
| Makers Laboratories | 1.11B |
| Asston Pharmaceuticals | 1.09B |
| Pharmaids Pharmaceuticals | 1.07B |
| Mercury Laboratories | 999.60M |